Microbial Identification and Antimicrobial Susceptibility Testing System

What is the Microbial Identification and Antimicrobial Susceptibility Testing System?

A microbial identification and antimicrobial susceptibility testing system automatically reads biochemical or growth panels to identify isolates and determine minimum inhibitory concentrations. It is the right choice for clinical microbiology laboratories that need standardized, traceable results for treatment decisions.

Overview

This variant holds disposable panels or cards in a temperature-controlled incubator and reads them optically at fixed intervals. Identification cards carry dried substrates that change color or fluorescence when utilized by the organism, and the software compares the pattern to a database of species profiles. Susceptibility cards contain serial antibiotic dilutions, and growth kinetics based on turbidity or fluorescence give MIC values within 4 to 18 hours for most bacteria. An expert system interprets results according to CLSI or EUCAST breakpoints and flags resistance mechanisms such as ESBL or MRSA. Typical capacity is 60 to 240 cards per instrument, with inoculum preparation by a turbidity meter, and connection to the LIS supports reporting and surveillance statistics.

How does it work?

Diagnostic analyzers combine a sample handling system, a reaction or sensing chamber and a detector specific to the measurand. Blood gas analyzers use ion-selective, Clark-type oxygen and Severinghaus-type carbon dioxide electrodes. HbA1c analyzers separate hemoglobin fractions by cation-exchange HPLC and detect them at 415 nm. Specific protein analyzers measure light scattering or turbidity produced when antibody-coated particles bind a protein, using nephelometry or immunoturbidimetry. Blood culture systems monitor carbon dioxide production by colorimetric or fluorescent sensors inside bottles to flag microbial growth. Identification and susceptibility systems measure turbidity and growth kinetics in panels containing substrates or antibiotics. Calibration with standards and periodic quality control ensure that results remain traceable and within acceptance limits.

What are the key features?

• Identification and susceptibility cards read optically at fixed intervals
• MIC determination within 4–18 hours for most bacteria
• Expert system interpretation using CLSI or EUCAST breakpoints
• Detection of resistance phenotypes such as ESBL and MRSA
• Standardized inoculum preparation with a turbidity meter
• Database updates and LIS connection for surveillance reporting

What are the technical specifications?

A typical microbial identification and antimicrobial susceptibility testing system configuration offers card capacity of 60–240 cards, incubation temperature of 35 ± 1 °C, identification time of 2–8 h for common bacteria, AST time of 4–18 h, antibiotic panel of Up to 20–30 antibiotics per card and inoculum density of 0.5–0.63 McFarland. Values are indicative of the product class; the exact figures for each configuration are confirmed on the quotation and the calibration documents supplied with the instrument.

Which applications is it used for?

The Microbial Identification and Antimicrobial Susceptibility Testing System is used in clinical bacteriology identification, antimicrobial resistance surveillance, hospital infection control and antibiotic stewardship support. Across the wider Diagnostic Analyzers class, laboratories also deploy it for critical care blood gas monitoring, diabetes control monitoring and inflammation and immune protein testing.

Which standards and certifications apply?

Relevant standards and methods include ISO 15189, IEC 61010-2-101, CLSI C46, CLSI EP15, ISO 18113-1, ISO 15197, CLSI M47 and CLSI M07. Certification candidates for this model are CE, ISO 13485 quality system and NMPA registration; each is to be confirmed for the specific configuration before shipment, and certificates are supplied only where they have been issued.

Install analyzers on stable benches with controlled temperature, stable power and adequate ventilation. Follow manufacturer schedules for electrode or column replacement, reagent pack changes and waste handling, and treat all specimens and waste as potentially infectious. Run quality control at defined intervals, participate in external quality assessment and verify performance on installation according to CLSI EP15. Blood gas analyzers require regular membrane and electrode maintenance and proper sample handling to avoid air bubbles. Blood culture instruments need a clean, vibration-free environment. Document calibration, maintenance and training under the laboratory quality system in line with ISO 15189, and plan service and spare parts support.

How do I select the right Microbial Identification and Antimicrobial Susceptibility Testing System?

Select a system sized to isolate volume and required panel coverage. Specify card capacity, organism types, breakpoint standard, expert rules, database update policy, LIS interface and reagent supply in the RFQ, and confirm that panels cover the antibiotics locally prescribed.

How does it compare with other Diagnostic Analyzers variants?

Choose the analyzer by the measurand and the clinical setting. Blood gas analyzers for critical care should provide results in under two minutes from small sample volumes, with integrated co-oximetry and electrolytes if needed. For diabetes programs, HbA1c analyzers should demonstrate traceability to IFCC and NGSP and throughput matching the clinic. Specific protein analyzers differ in menu, sample dilution and calibration stability. Microbiology systems should match bottle capacity to blood culture volume. Compare reagent and consumable availability, maintenance demands, onboard calibration, LIS connectivity and operator training. Request evidence such as precision, interference testing and method comparison, and confirm the registration status of reagents in your market.